Literature DB >> 25824763

Effects of metformin on cell kinetic parameters of MCF-7 breast cancer cells in vitro.

Mehmet Topcul1, Idil Cetin.   

Abstract

In this study, the antiproliferative effects of the metformin was evaluated on MCF-7 Cells (human breast adenocarcinoma cell line). For this purpose cell kinetic parameters including cell proliferation assay, mitotic index and labelling index analysis were used. 30 μM, 65 μM and 130 μM Metformin doses were applied to cells for 24, 48 and 72 hours. The results showed that there was a significant decrease in cell proliferation, mitotic index and labelling index for all experimental groups (p<0.05) for all applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824763     DOI: 10.7314/apjcp.2015.16.6.2351

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.

Authors:  Rabah Rashad Falah; Wamidh H Talib; Seba Jamal Shbailat
Journal:  Ther Adv Med Oncol       Date:  2017-02-01       Impact factor: 8.168

2.  Metformin synergistically increases the anticancer effects of lapatinib through induction of apoptosis and modulation of Akt/AMPK pathway in SK-BR3 breast cancer cell line.

Authors:  Davood Neamati; Azam Khedri; Mohammad Aberomand; Ali-Asghar Hemmati; Maryam Mohammadzadeh; Kourosh Akbari Baghbani; Ghorban Mohammadzadeh
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.